Publication Date:
2022
abstract:
Intermediate risk prostate cancer (IR PCa) may exhibit a wide array of phenotypes, from favorable to unfavorable. NCCN criteria help distinguishing between favorable versus unfavorable subgroups. We studied and attempted to improve this classification.
Iris type:
1.1 Articolo in rivista
List of contributors:
Nocera, Luigi; Collà Ruvolo, Claudia; Stolzenbach, Lara F; Deuker, Marina; Tian, Zhe; Gandaglia, Giorgio; Fossati, Nicola; Abdollah, Firas; Suardi, Nazareno; Mirone, Vincenzo; Graefen, Markus; Chun, Felix K; Saad, Fred; Montorsi, Francesco; Briganti, Alberto; Karakiewicz, Pierre I
Published in: